Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Acquires Sequencing Technology Developer GnuBio

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories has purchased next-generation sequencing technology firm GnuBio for an undisclosed price in order to give it capabilities in the NGS space, especially for clinical applications, Bio-Rad said this week.

Cambridge, Mass.-based GnuBio is developing a droplet-based sequencing platform that uses "picoinjector" technology developed in co-founder David Weitz’s physics laboratory at Harvard University.

"We believe GnuBio's innovative DNA workflow is well-suited for the clinical diagnostics sequencing market and will leverage Bio-Rad's leadership role in the area of droplet digital PCR," Bio-Rad President and CEO Norman Schwartz said in a statement.

GnuBio has said that it is developing its platform specifically for the clinical market. The platform incorporates microfluidics and uses a picoinjector to inject 1-kilobase sized DNA fragments into microdroplets containing PCR fragments representing the amplicon to be sequenced.

The firm raised $10 million in a Series B round of financing last year and $8 million in a Series A round of financing in 2012. It began shipping its system to beta testers last year, and as reported by In Sequence, unveiled its platform as well as some accuracy data from 24 runs of a 36-gene panel at the Consumer Genetics Conference in Boston last year.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.